Study Summary
The main purpose of this study is to verify the safety and potential effectiveness of CART cells combined with peptide specific dendritic cell in relapsed/refractory leukemia.
Want to learn more about this trial?
Request More InfoInterventions
Chimeric antigen receptor T cellsBIOLOGICAL
After pretreatment, chimeric antigen receptor T cells will be transfused.
peptide specific dendritic cellBIOLOGICAL
After transfusion of chimeric antigen receptor T cells, Eps8 or WT1 peptide specific dendritic cell were intradermal injected.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Zhujiang Hospital, Southern Medical University | Guangzhou | Guangdong | China |